Health Sciences nyilvános
[search 0]
Több
Download the App!
show episodes
 
The EY Health Sciences and Wellness Experience podcast explores the age of “Health Experience.” All who use and touch the heath care value chain will soon demand a service that provides a more personalized and enhanced outcome. Join us and our guests, as we expand the traditional definitions of innovation to meet ever growing needs and expectations.
  continue reading
 
Hi, you’re listening to Postdocalypse, a podcast by postgrad students about all things postgrad. The name comes from the idea that once you finish your PhD, there’s the big question for all of us whether we’ll continue along the academic path or take on of the many alternative routes that are on offer to us. We’re a team of PhD students at King’s College London, trying to navigate this crazy world and we’ll be sharing the highs and the lows of postgraduate study.
  continue reading
 
“In the Beginning was the Word...the Word became flesh and dwelt among us…” for those of us at Florida Hospital College, words mean more than just what we speak. We believe that long ago, words created the world, and since then words continue to create life in both ourselves and in others. Which is why we started this project, inspired by StoryCorps, to capture the words of our students, faculty, and staff. Words that in different ways, describe this ministry we call healthcare.
  continue reading
 
BDO’s Health & Life Sciences Rx Podcast, hosted by The BDO Center for Healthcare Excellence & Innovation and the Life Sciences practice, seeks to provide insights into the trends disrupting healthcare and how companies can adapt and evolve in an ever-changing business landscape.
  continue reading
 
Loading …
show series
 
In this episode of the EY Health Sciences and Wellness Experience Podcast, Aloha McBride and her guests explore health inequity, sustainable change and environmental impact of the health industry. Our panel of experts discuss the evolution of sustainability in health. The explore where organizations can start on their sustainability journey, how th…
  continue reading
 
In today's episode we focus on the EY report on the Pharma supply chains of the future, and discuss the impact of global events and how a new supply chain model can emerge in the pharma industry. The speakers discuss the future of pharmaceutical supply chains in the wake of the COVID-19 pandemic and other geopolitical events and shifts that are unf…
  continue reading
 
In this episode, Barend van Bergen, EY Global Long-term Value Methodology Leader and Sonja Haut, Head of Impact Valuation for Novartis discuss how companies are measuring their ESG impact. Together they review the growing importance of sustainable health solutions, ESG in healthcare and sustainability reporting in the Health Sciences and Wellness i…
  continue reading
 
In this episode of the EY Health Sciences and Wellness Experience podcast, Pamela Spence, EY Global Health Sciences and Wellness Leader, talks with Nancy Flores, Executive Vice President & Chief Information and Technology Officer for McKesson Corporation and look into innovation in healthcare and health care data science. They discuss the unique co…
  continue reading
 
In this episode of the EY Health Sciences and Wellness Experience podcast we focus on women in health. Join Pamela Spence, EY Global Health Sciences and Wellness Leader, as she speaks with Trecilla Lobo, SVP, People, BenevolentAI, Rabia Khan, Founder/CEO, Ladder Therapeutics, and Samin Saeed, UK Chief Scientific Officer and Medical Director, Novart…
  continue reading
 
In this episode of the EY Health Sciences and Wellness Experience Podcast, Pamela Spence, EY Global Health Sciences and Wellness Leader, Jackie Hunter, Board Director of Benevolent AI and Ridwaan Jhetam, VP Global Medical for Haematology, BMS, discuss the importance of data science in healthcare and how it can help redesign the health experience an…
  continue reading
 
There are 2,600 gen and cell therapy clinical trials taking place this year. In the US alone, this could translate up to 20 new therapy approvals in 2022, which presents a clear opportunity to make more life-saving therapies available to a greater number of individuals. As the evolution of medicine continues, the future looks promising for advancem…
  continue reading
 
In this episode, we delve into the global challenge of addressing health inequality with Dr. Yele Aluko, EY Chief Medical Officer, and Dr. David Rhew, Microsoft Chief Medical Officer. As experienced physicians, they share their passion for finding opportunities to provide health equity and discuss the root causes of disparities and how unbiased dig…
  continue reading
 
In this first episode of our EY Health Sciences and Wellness Experience podcast series, we explore the emerging and much needed age of “Health Experience” and the disruptive health innovation emerging in the aftermath of the covid 19 pandemic. The Covid 19 impact on healthcare was immense and Health Sciences and Wellness industry has never been as …
  continue reading
 
Welcome to Postdocalypse on Lockdown! This episode is a re-release of our "Cohabitants on COVID" episode. We have all been busy in the labs since we were allowed back in to work but we hope you'll forgive us... we will get back to filling your ears with sciencey sounds ASAP!In this re-release, we corner our flatmates to talk about working on COVID …
  continue reading
 
The drug development process is costly, time consuming and laden with risk—with only 1% of drugs making it from pre-clinical all the way to market, according to Pharma Intelligence. To beat these odds, life sciences leaders must know when to continue funding a promising, new product and when to call it quits. Tune in for insights into: Why a “fast …
  continue reading
 
Welcome to Postdocalypse on Lockdown!Some Postdocalypse team members corner their flatmates to talk about working on COVID in this socially distant episode! We answer some of your burning COVID FAQs and some Qs you didn't know you had when we talk to a doctor and a scientist who have both taken time out of their training to work on the front lines …
  continue reading
 
Welcome to episode 7 of Postdocalypse 2019! This podcast is produced by health sciences postgraduate researchers at King's College London.This month we have a special guest! We met Anne-Marie Coriat, Head of UK and EU Research Landscape at the Wellcome Trust, at VItae Conference and we are so excited to have picked her brains about the changing fac…
  continue reading
 
Welcome to the episode 6 of Postdocalypse 2019! This podcast is produced by health sciences postgraduate researchers at King's College London.This episode was recorded ***live*** at Vitae International Researcher Development Conference, where we led a special interest session with KCL’s Careers in Your Ears! This episode concerns how to get researc…
  continue reading
 
In this episode of BDO’s Health & Life Sciences Rx Podcast, BDO’s Todd Berry sits down with leaders from Universal Cells, Fortress Biotech, and McDermott Will & Emery to discuss how leaders in biotech can assess the current M&A and IPO landscape to choose the right exit strategy for their organization.…
  continue reading
 
Welcome to the episode 5 of Postdocalypse 2019! This podcast is produced by health sciences postgraduate researchers at King's College London.This month we have a very special treat for listeners - a whole episode dedicated to open science - What is it? Why should we be talking about it? And how is it changing the face of research? Ale Lautarescu i…
  continue reading
 
It's our 4th Postdocalypse episode of 2019! You know what they say...4th time's a charm. Right? That's definitely what they say. They also say that this podcast is produced by Health Sciences PhD researchers at King's College London. In this episode we will hear about Olatz's PhD research into the complex and difficult-to-quantify relationship betw…
  continue reading
 
The third episode of 2019 has dropped! This podcast is produced by Health Sciences PhD researchers at King's College London. This a career special where Madeleine Iafrate interviews two speical guests, Dr's Samantha Terry and Daniel Burnham. They discuss the practicalities of being academics in a relationship and maintaining a good work life balanc…
  continue reading
 
Welcome to the second Postdocalypse episode of 2019! This podcast is produced by Health Sciences PhD researchers at King's College London.In this episode, we will help you sort out your life! Just kidding, but we will interview Donald Lush from the Careers & Employability office who has some reassuring advice about post-PhD options. Don't worry, yo…
  continue reading
 
Tune in for insights on: The convergence of senior healthcare and housing—and implications for healthcare REITs and private equity professionals The operational and hospitality components that make senior housing and skilled nursing facilities attractive investment prospects The importance of providing education to seniors—and their caregivers—on a…
  continue reading
 
Welcome to the first Postdocalypse episode of 2019! This podcast is produced by health sciences postgraduate researchers at King's College London.In this episode, Haris Shuaib interviews Katie Begg about her PhD research investigating the cellular mechanisms behind radiotherapy response in head and neck cancer. Later in the episode they are joined …
  continue reading
 
Seniors—the fastest-growing U.S. age demographic—are poised to make up more than 20 percent of the U.S. population by 2029. And they’re moving to the driver’s seat of care. Now, they’re demanding elder care more rooted in empathy and designed on their own terms—and in their preferred environment. With these shifts, new types of entities—including t…
  continue reading
 
The growth of the aging population—and providing proper care to that population—is an urgent challenge facing the global economy. Although each market has its own regulatory and cultural intricacies, we’ve found an antidote becoming more common across borders: an empathy-based elder care system focused on preserving independence.…
  continue reading
 
Welcome to the seventh episode of Postdocalypse, produced by health sciences postgraduate researchers at King's College London.This episode is hosted by Emily Prpa interviewing Dr Francis Smith about Treacher Collins Syndrome, research motivation and anglophilia. Dr Smith talks to us about his experience of living with Treacher Collins Syndrome and…
  continue reading
 
With KKR's $10 billion purchase of Envision Healthcare this summer, the largest healthcare buyout deal since the financial crisis, private equity's appetite for healthcare deals might well be stronger than ever. Meanwhile, with Amazon's emerging healthcare arm and an imminent deal between CVS and Aetna, providers are turning to digital innovation t…
  continue reading
 
Welcome to the sixth episode of Postdocalypse, produced by health sciences postgraduate researchers at King's College London.This episode is hosted by Haris Shuaib interviewing Joe Barnby about his research into the role of dopamine in psychosis, and how he founded and set up his very own company alongside his PhD studies.Joe tells us about the sta…
  continue reading
 
Welcome to the fifth episode of Postdocalypse, produced by health sciences postgraduate researchers at King's College London.This episode is hosted by Katie Begg interviewing Mads Iafrate about her research in cell tracking that aims to improve efficacy and safety of cell therapies for cancer patients. Mads discusses how she uses molecular biology …
  continue reading
 
Welcome to the fourth episode of Postdocalypse, produced by health sciences postgraduate researchers at King's College London.This episode is hosted by Alexandra Lautarescu, interviewing Elisa Brann about her research into the neuroscience behind verbal-auditory hallucinations, otherwise known as voice-hearing. Elisa discusses how she uses hypnosis…
  continue reading
 
‘Does an apple a day keep the doctor away?’Welcome to the third episode of Postdocalypse, produced by health sciences postgraduate researchers at King's College London.This episode is hosted by Michael Norman from the Dental Institute, interviewing Emily Prpa from Nutritional Sciences about her research on the effects of polyphenols, commonly found…
  continue reading
 
Tune in to the full episode to hear about: The exponential growth in genetic testing and genomic technologies New drug therapies that are based on live organisms Innovation in technology platforms connecting patients, providers, payers, industry, and investorsBDO USA által
  continue reading
 
Welcome to the second episode of Postdocalypse, produced by health sciences postgraduate researchers at King's College London.This episode is hosted by Elisa Brann, interviewing Alexandra Lautarescu about her research in neurodevelopment and mental health. In the second discussion, Elisa and Ale discuss mental health and wellbeing as a postgraduate…
  continue reading
 
Dr. Karen De Salvo—Professor of Medicine & Population Health, UT Austin Dell Medical School, former US Assistant Secretary for Health (Acting) & National Coordinator for Health IT—talks with Patrick Pilch, Managing Director and National Leader of BDO’s healthcare advisory practice, about the future of digital health and how data can be leveraged fo…
  continue reading
 
Welcome to the inaugural episode of Postdocalypse, produced by health sciences postgraduate researchers at King's College London.This episode is hosted by Emily Prpa, interviewing Haris Shuaib about his research in applying Artificial Intelligence to brain tumour prognosis. In the second discussion, Emily and Haris discuss orthodox and unorthodox p…
  continue reading
 
Anisa is a 54-year-old with hypertension and stage 3 chronic kidney disease (but not diabetes mellitus) and LDL-C <190 mg/dL despite high-intensity statin therapy. Results of clinical trials show that reducing atherogenic lipoproteins to very low levels (LDL-C <50 mg/dL) is beneficial in reducing the risk of a cardiovascular event compared to highe…
  continue reading
 
Patients who receive a prescription for statin therapy often remain at increased cardiovascular risk due to elevated low-density lipoprotein cholesterol (LDL-C). Organizations such as the American College of Cardiology, American Heart Association, and National Lipid Association have developed algorithms to guide the management of patients with LDL-…
  continue reading
 
Livia_Nagy.JPG "...My Papa passed away when I was 15 but since then his optimism has lived on inside of me..." Lyvia Nagy, General Studies Student Listen Now Nagy_Lyvia.mp3 Transcript When I was six my Papa had a liver transplant which saved his life. Because of the transplant I was able to spend nine extra years with him, during which our family h…
  continue reading
 
Loading …

Gyors referencia kézikönyv